Novel truncating variants in FGD1 detected in two Danish families with Aarskog–Scott syndrome and myopathic features
Authors:
Open Access
- 7 April 2022
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 188 (7) , 2251-2257
Abstract
Aarskog–Scott syndrome (AAS) is a developmental disorder, caused by disease‐causing hemizygous variants in the FGD1 gene. AAS is characterized by dysmorphic features, genital malformation, skeletal anomalies, and in some cases, intellectual disability and behavioral difficulties. Myopathy has only been reported once in two affected siblings diagnosed with AAS. Only few adult cases have been reported. This article reports four adults with AAS (three male cases and one female carrier) from two unrelated Danish families, all males presented with variable features suggestive of myopathy. All four carried novel hemizygous pathogenic variants in the FGD1 gene; one family presented with the c.2266dup, p.Cys756Leufs*19 variant while the c.527dup; p.Leu177Thrfs*40 variant was detected in the second family. All males had some mild myopathic symptoms or histological abnormalities. Case 1 had the most severe myopathic phenotype with prominent proximal muscular fatigue and exercise intolerance. In addition, he had multiple deletions of mtDNA and low respiratory chain activity. His younger nephew, case 3, had difficulties doing sports in his youth and had a mildly abnormal muscle biopsy and relatively decreased mitochondrial enzyme activity. The singular case from family 2 (case 4), had a mildly myopathic muscle biopsy, but no overt myopathic symptoms. Our findings suggest that myopathic involvement should be considered in AAS.Keywords
This publication has 25 references indexed in Scilit:
- Exome Sequencing Identifies A Branch Point Variant in Aarskog-Scott SyndromeHuman Mutation, 2013
- Aarskog‐Scott syndrome: first report of a duplication in the FGD1 geneClinical Genetics, 2011
- Fraternal twins with Aarskog–Scott syndrome due to maternal germline mosaicismAmerican Journal of Medical Genetics Part A, 2011
- Aarskog–Scott syndrome: Clinical update and report of nine novel mutations of the FGD1 geneAmerican Journal of Medical Genetics Part A, 2010
- Unilateral focal polymicrogyria in a patient with classical Aarskog–Scott syndrome due to a novel missense mutation in an evolutionary conserved RhoGEF domain of the faciogenital dysplasia gene FGD1American Journal of Medical Genetics Part A, 2007
- Unusually severe expression of craniofacial features in Aarskog‐Scott syndrome due to a novel truncating mutation of the FGD1 geneAmerican Journal of Medical Genetics Part A, 2006
- Phenotypic and molecular characterisation of the Aarskog–Scott syndrome: a survey of the clinical variability in light of FGD1 mutation analysis in 46 patientsEuropean Journal of Human Genetics, 2003
- Two novel mutations confirm FGD1 is responsible for the Aarskog syndromeEuropean Journal of Human Genetics, 2000
- Isolation and characterization of the faciogenital dysplasia (Aarskog-Scott syndrome) gene: A putative RhoRac guanine nucleotide exchange factorCell, 1994
- Aarskog syndrome: Report of a family with review and discussion of nosologyAmerican Journal of Medical Genetics, 1993